The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
758 - In the PAAB Fair Balance guidance, for lowest level FB, it states "messages which do not relate to the healthcare product (e.g. disease information)". Question is: If the message does not relate to the product and only disease info, why would we require any FB at all? it is not advertising. Or could you provide an example for this scenario?
-
You’ll note that the “Scope” of the document states “This document applies only to healthcare professional advertising/promotions systems (APS) that require fair balance per PAAB code 2.1, 2.4, 3.5 and 7.3”.
Mention of the brand or branding elements, and discussion of disease content would suggest the therapeutic use without properly limiting to the specifics of the products indication. The brands indication and lowest level fair balance should be presented so as to accurately convey the limitations of use.
